Interestingly, methylation detection of SHOX2 in sputum, blood, alveolar lavage fluid, and tissue of patients has been used to screen early lung cancer patients (Zhao et al., 2015; Weiss et al., 2017; Zhang et al., 2017; Shi et al., 2020). This evidence concerns the gene SHOX2 and lung cancer.